Abstract 5166: A multiplexed immunofluorescence assay to assess Rb and phospho-Rb as predictive biomarkers for CDK4/6 inhibitors in HR+/HER2- breast cancer
Mantasha Tabassum(University of Houston), Meghana V. Trivedi(University of Houston), George Miles(Baylor College of Medicine), Mothaffar F. Rimawi(Baylor College of Medicine), Wangjia Cao(University of Houston), Shivaani Suresh Kanna(University of Houston)
Cited by 0
Related Papers
Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function
|Cancer Research|2008|494
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485
Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2013|273